Answers are grounded in this paper and cite their sources.
Multi-subject spatial transcriptomics is increasingly used to identify molecular differences across individuals and conditions while resolving where in tissue those differences occur. Yet subject-level differential expression (DE) analyses commonly require spatial regions to be specified in advance, separating localization from testing. Here we present SpaceDX, a framework that uses gene-specific attention-based spatial weighting to jointly test differential expression and localize the spatial expression patterns contributing to these associations. In simulations, SpaceDX outperforms cluster-based DE methods when differential expression does not align with predefined spatial boundaries. Across two multi-subject mouse brain datasets, SpaceDX detected 45.8% more DE genes than regional DESeq2 pseudobulk in a chronic stress model, while in an Alzheimer's disease model combining SpaceDX with DESeq2 increased discovery by 19.1% relative to DESeq2 alone. Across both datasets, the learned maps provided spatial context for condition-associated expression signals in addition to gene-level significance. In the chronic stress model, for example, oligodendrocyte- and myelin-associated genes showed shared localization to corresponding brain structures. Together, these results show that the spatial context of differential expression can be inferred jointly with gene-level associations, recovering signals obscured by regional aggregation without requiring the relevant tissue context to be defined in advance.
No takes yet. Share an insight, caveat, or question.
Stotzem et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: